                               SEQUENCE LISTING

<110> GRITSTONE ONCOLOGY, INC.
 
<120> NEOANTIGEN IDENTIFICATION, MANUFACTURE, AND USE

<130> 32669-40594/WO

<140> PCT/US2018/036571
<141> 2018-06-08

<150> 62/517,786
<151> 2017-06-09

<160> 22    

<170> PatentIn version 3.5

<210> 1
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Tyr Val Tyr Val Ala Asp Val Ala Ala Lys 
1               5                   10  


<210> 2
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Tyr Glu Met Phe Asn Asp Lys Ser Gln Arg Ala Pro Asp Asp Lys Met 
1               5                   10                  15      


Phe 
    


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Tyr Glu Met Phe Asn Asp Lys Ser Phe 
1               5                   


<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Pyrrolysine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Ile or Leu

<400> 4
His Arg Xaa Glu Ile Phe Ser His Asp Phe Xaa 
1               5                   10      


<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Pyrrolysine 

<400> 5
Phe Xaa Ile Glu Xaa Phe Xaa Glu Ser Ser 
1               5                   10  


<210> 6
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Pyrrolysine 

<400> 6
Asn Glu Ile Xaa Arg Glu Ile Arg Glu Ile 
1               5                   10  


<210> 7
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Selenocysteine

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Ile or Leu 

<400> 7
Xaa Phe Lys Ser Ile Phe Glu Met Met Ser Xaa Asp Ser Ser Xaa Ile 
1               5                   10                  15      


Phe Leu Lys Ser Xaa Phe Ile Glu Ile Phe Xaa 
            20                  25          


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Pyrrolysine 

<400> 8
Lys Asn Phe Leu Glu Asn Phe Ile Glu Ser Xaa Phe Ile 
1               5                   10              


<210> 9
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Ile or Leu 

<400> 9
Phe Xaa Glu Ile Phe Asn Asp Lys Ser Leu Asp Lys Phe Xaa Ile 
1               5                   10                  15  


<210> 10
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ile or Leu 

<400> 10
Gln Cys Glu Ile Xaa Trp Ala Arg Glu Phe Leu Lys Glu Ile Gly Xaa 
1               5                   10                  15      


<210> 11
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Selenocysteine 

<400> 11
Phe Ile Glu Xaa His Phe Trp Ile 
1               5               


<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (7)..(7)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Selenocysteine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Ile or Leu 

<400> 12
Phe Glu Trp Arg His Arg Xaa Thr Arg Xaa Xaa Arg 
1               5                   10          


<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ile or Leu 

<400> 13
Gln Ile Glu Xaa Xaa Glu Ile Xaa Glu 
1               5                   


<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Pyrrolysine 

<400> 14
Gln Cys Glu Ile Xaa Trp Ala Arg Glu 
1               5                   


<210> 15
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Ile or Leu 

<400> 15
Phe Xaa Glu Leu Phe Ile Ser Asx Xaa Ser Xaa Phe Ile Glu 
1               5                   10                  


<210> 16
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Ile or Leu 

<400> 16
Ile Glu Phe Arg Xaa Glu Ile Phe Xaa Glu Phe 
1               5                   10      


<210> 17
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Ile or Leu 

<400> 17
Ile Glu Phe Arg Xaa Glu Ile Phe Xaa 
1               5                   


<210> 18
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ile or Leu 

<400> 18
Glu Phe Arg Xaa Glu Ile Phe Xaa Glu 
1               5                   


<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Ile or Leu 

<400> 19
Phe Arg Xaa Glu Ile Phe Xaa Glu Phe 
1               5                   


<210> 20
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Tyr Glu Met Phe Asn Asp Lys Ser Phe Gln Arg Ala Pro Asp Asp Lys 
1               5                   10                  15      


Met Phe 
        


<210> 21
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (6)..(6)
<223> Selenocysteine 

<220>
<221> MOD_RES
<222> (7)..(8)
<223> Pyrrolysine 

<400> 21
Phe Glu Gly Arg Lys Xaa Xaa Xaa Ile 
1               5                   


<210> 22
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Pyrrolysine 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Ile or Leu 

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Pyrrolysine 

<400> 22
Pro Xaa Phe Ile Xaa Glu Xaa Xaa Ile Xaa Gly Glu Ile Xaa 
1               5                   10                  

